患者招募_健趣网

Row	Study Title	Conditions	Interventions	Detail
333	Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response	Healthy Volunteer	Drug:Phenelzine Drug:Tyramine Drug:Phenelzine placebo Drug:ozanimod placebo Drug:ozanimod	detail
334	T.E.A.M. Feasibility and Efficacy Study 2.0	Depression, Anxiety	Behavioral:TEAM PSYCHOTHERAPY	detail
335	Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis	Hyperhidrosis	:	detail
336	Calcium Electroporation for Early Colorectal Cancer	Colorectal Cancer	Combination Product:Calcium electroporation	detail
337	Androgenetic Alopecia and the JAK-STAT Pathway	Androgenetic Alopecia	Other:Punch skin biopsy	detail
338	Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers	Lung Cancer	Other:Care coordination tool	detail
339	Safety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers	Healthy\|Safety	Drug:SAD: APX-115 Drug:SAD: Placebo Drug:MAD: APX-115 Drug:MAD: Placebo Other:Food effect: fasted or fed Other:APX-115 with or without a metabolic probe	detail
340	Neuromuscular and Biomechanical Control of Lower Limb Loading in Individuals With Chronic Stroke	Stroke\|Hemiparesis	Other:Limb Loading Other:Conventional Training	detail
341	SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases	Neoplasm Metastasis\|Neoplastic Processes\|Neoplasms\|Pathologic Processes	Radiation:SUPR Radiation:VMAT	detail
342	Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery	Locally Advanced Thymic Carcinoma\|Metastatic Thymic Carcinoma\|Recurrent Thymic Carcinoma\|Unresectable Thymic Carcinoma	Drug:Carboplatin Drug:Paclitaxel Biological:Ramucirumab	detail

上一页 27 28 29 30 31 32 33 下一页为您找到500条信息